Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection

Cell Host & Microbe(2021)10.1016/j.chom.2021.04.005Source: DataRank Database

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection is a research paper published in Cell Host & Microbe (2021). On theSindex it has a DataRank of 0.644. It has been cited 72 times.

N/A

0.644DataRank · unranked

Scored on demand from live citation data

Open Access72 citations

Download PDF

Cite:

Linked data & code

cellosaurus gen emdb pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 3.76)OA: hybridTopics (72)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.644

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (20)

Meng Yuan ORCID,Deli Huang ORCID,Sandhya Bangaru ORCID,Fangzhu Zhao ORCID,Chang‐Chun D. Lee ORCID

Live enrichment

PubMed:33894127 PMC:PMC8049401 OpenAlex:https://openalex.org/W3155405767

Argonne National Laboratory

Grant: DE-AC02-06CH11357

Bill and Melinda Gates Foundation

Grant: OPP1170236

Bill and Melinda Gates Foundation

Grant: INV-004923

NIH

Grant: R00 AI139445

NIH

Grant: R01 AI132317

Deutsches Zentrum für Neurodegenerative Erkrankungen

Grant: 2020-039EP-PR

National Institutes of Health

Grant: 5R01AI132317-02

Germline targeting influenza immunogens

National Institutes of Health

Grant: 4R00AI139445-03

MECHANISTIC UNDERSTANDING OF INFLUENZA-HOST INTERACTIONS FROM A ZOONOTIC PERSPECTIVE

NIH

Bill and Melinda Gates Foundation

FWCI

3.76

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.chom.2021.04.005

publisherhttps://doi.org/10.1016/j.chom.2021.04.005

publisherhttps://api.elsevier.com/content/article/PII:S1931312821001815?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1931312821001815?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33894127

Fields of Study

SARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyBacteriophages and microbial interactions0301 basic medicine03 medical and health sciences0303 health sciencesAngiotensin-Converting Enzyme 2Antibodies, NeutralizingAntibodies, ViralCOVID-19Cross ReactionsHumansSevere acute respiratory syndrome-related coronavirusSARS-CoV-2Severe Acute Respiratory SyndromeSpike Glycoprotein, Coronavirus

MeSH Terms

Angiotensin-Converting Enzyme 2COVID-19SARS-CoV-2Antibodies, ViralCross ReactionsHumansSevere Acute Respiratory SyndromeSevere acute respiratory syndrome-related coronavirusAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

BiologyVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AntibodyCoronavirus disease 2019 (COVID-19)Neutralizing antibody2019-20 coronavirus outbreakNeutralizationSars virusImmunologyVirusDiseaseInfectious disease (medical specialty)OutbreakMedicineAntibody cocktailCrystallographyCoronavirussynergy3D structureAntibody-antigen InteractionCross-neutralizing AntibodyCovid-19Sars-cov-2Antibodies, Viral: immunologySevere Acute Respiratory Syndrome: prevention & controlAngiotensin-Converting Enzyme 2: metabolismACE2 protein, humanCross ReactionsAntibodies, ViralSevere Acute Respiratory SyndromeArticleAntibodies, Viral: chemistrySARS-CoV-2: immunologyHumansAntibodies, Neutralizing: chemistrySARS Virus: immunologySevere acute respiratory syndrome-related coronavirus: immunologyinfo:eu-repo/classification/ddc/570Spike Glycoprotein, Coronavirus: metabolismAntibodies, NeutralizingCOVID-19: prevention & controlSevere acute respiratory syndrome-related coronavirusSpike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2Antibodies, Neutralizing: immunology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review

10.6084/m9.figshare.20252899.v1figshare

Additional file 1 of Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review

10.6084/m9.figshare.20252899figshare

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection

FAIR Checklist

DataRank Breakdown

Authors (20)

Funding (10 grants)

Impact

Open Access

Topics

Linked Datasets (2)

Annotations (Europe PMC)